Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine
GlobeNewswire
· *If approved, IXCHIQ*^*®** will become the first vaccine available in the EU against the chikungunya virus (CHIKV)*
·..
· *If approved, IXCHIQ*^*®** will become the first vaccine available in the EU against the chikungunya virus (CHIKV)*
·..
*REYKJAVIK, ICELAND / ACCESSWIRE / May 14, 2024 / *GreenBank Capital (CSE:GBC)(OTC Pink:GRNBF)(FRA:2TL) ("*GreenBank*" or "*the..
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- *Cognition Therapeutics, Inc.* (the “Company” or “Cognition”) (NASDAQ: CGTX),..